DCF Advisers’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.7K | Sell |
10,770
-11,000
| -51% | -$42.6K | 0.02% | 74 |
|
|
2025
Q1 | $109K | Buy |
+21,770
| New | +$109K | 0.05% | 73 |
|
|
2024
Q4 | – | Sell |
-37,868
| Closed | -$233K | – | 81 |
|
|
2024
Q3 | $233K | Sell |
37,868
-5,000
| -12% | -$30.7K | 0.09% | 72 |
|
|
2024
Q2 | $285K | Sell |
42,868
-53,357
| -55% | -$355K | 0.15% | 74 |
|
|
2024
Q1 | $980K | Sell |
96,225
-19,000
| -16% | -$193K | 0.48% | 41 |
|
|
2023
Q4 | $1.3M | Sell |
115,225
-4,750
| -4% | -$53.4K | 0.7% | 32 |
|
|
2023
Q3 | $312K | Hold |
119,975
| – | – | 0.17% | 59 |
|
|
2023
Q2 | $424K | Buy |
119,975
+43,000
| +56% | +$152K | 0.22% | 56 |
|
|
2023
Q1 | $325K | Sell |
76,975
-3,705
| -5% | -$15.6K | 0.2% | 51 |
|
|
2022
Q4 | $1.33M | Sell |
80,680
-148,320
| -65% | -$2.44M | 0.9% | 26 |
|
|
2022
Q3 | $2.92M | Sell |
229,000
-106,180
| -32% | -$1.36M | 1.89% | 17 |
|
|
2022
Q2 | $3.92M | Buy |
335,180
+19,180
| +6% | +$224K | 2.34% | 12 |
|
|
2022
Q1 | $1.92M | Buy |
316,000
+35,300
| +13% | +$215K | 0.84% | 31 |
|
|
2021
Q4 | $2.57M | Buy |
280,700
+41,500
| +17% | +$380K | 1.04% | 26 |
|
|
2021
Q3 | $2.71M | Buy |
239,200
+93,450
| +64% | +$1.06M | 1.19% | 22 |
|
|
2021
Q2 | $1.44M | Buy |
+145,750
| New | +$1.44M | 0.51% | 35 |
|